Matt Lunning, D.O. FACP

No bio available.

Financial relationships

  • Attribution:
    Self
    Nature of financial relationship:
    Professional Services
    Ineligible company:
    Kite
    Topic:
    Consultant
    Date added:
    02/01/2024
    Date updated:
    02/01/2024
  • Attribution:
    Self
    Nature of financial relationship:
    Professional Services
    Ineligible company:
    Loxo
    Topic:
    Consultant
    Date added:
    02/01/2024
    Date updated:
    02/01/2024
  • Attribution:
    Self
    Nature of financial relationship:
    Professional Services
    Ineligible company:
    Nurix
    Topic:
    Consultant
    Date added:
    02/01/2024
    Date updated:
    02/01/2024
  • Attribution:
    Self
    Nature of financial relationship:
    Professional Services
    Ineligible company:
    Recordati
    Topic:
    Consultant
    Date added:
    02/01/2024
    Date updated:
    02/01/2024
  • Attribution:
    Self
    Nature of financial relationship:
    Professional Services
    Ineligible company:
    Regeneron
    Topic:
    Consultant
    Date added:
    02/01/2024
    Date updated:
    02/01/2024
  • Attribution:
    Self
    Nature of financial relationship:
    Professional Services
    Ineligible company:
    SeaGen
    Topic:
    Consultant
    Date added:
    02/01/2024
    Date updated:
    02/01/2024
  • Attribution:
    Self
    Nature of financial relationship:
    Professional Services
    Ineligible company:
    Takeda
    Topic:
    Consultant
    Date added:
    02/01/2024
    Date updated:
    02/01/2024
  • Attribution:
    Self
    Nature of financial relationship:
    Professional Services
    Ineligible company:
    ViTToria
    Topic:
    Consultant
    Date added:
    02/01/2024
    Date updated:
    02/01/2024

Pages

Return to 13th Annual Updates in the Treatment and Management of Hematologic Malignancies Highlights from San Diego